Pfizer has been trying to get in on the billion-dollar weight loss drug market. Novo Nordisk initially dominated this market but has been losing ground to Eli Lilly. 10 stocks we like better than ...
As you plan your holiday giving this year, PennLive encourages you to take a look at its annual “Wish List” of goods and ...
Valmont has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14%. The stock now trades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results